Spectrum Dynamics
8
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
1 terminated/withdrawn out of 8 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Role: lead
Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera
Role: lead
Study to Compare a Fast Gama Camera for Nuclear Imaging to Conventional Camera
Role: lead
Ganglionated Plexus Ablation For Treatment of Atrial Fibrillation
Role: lead
Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology
Role: collaborator
Assessment of Coronary Flow Reserve by PET-H215O and FFR. Comparison With Dynamic Acquisition Using CZT Camera
Role: collaborator
Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI
Role: collaborator
Validation of Quantitative Ventricular Function Imaging Single Photon Emission Tomography (Spect)Using the D-SPECT Cardiac Camera
Role: lead
All 8 trials loaded